A股異動丨今世緣(603369.SH)逼近漲停 中期淨利增30.92% 加快D20/D30佈局培育
格隆匯8月25日丨今世緣(603369.SH)大幅拉昇逼近漲停,半日成交額近9億元,現報46.39元,總市值582億元。今世緣24日披露半年報,公司上半年營收38.5億元,同比增長32.2%;淨利潤13.35億元,同比增長30.92%。報吿期內,公司加快結構升級,出台了今世緣品牌激活戰運作計劃、營銷策略優化等指導方案。加快D20/D30佈局培育,統籌配稱推廣資源,促進了品牌激活。此外,招商中證白酒指數基金持股由3.19%增至3.5%,香港中央結算持股由4.03%降至3.82%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.